Correlation Between Arcellx and Structure Therapeutics

Can any of the company-specific risk be diversified away by investing in both Arcellx and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcellx and Structure Therapeutics American, you can compare the effects of market volatilities on Arcellx and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Structure Therapeutics.

Diversification Opportunities for Arcellx and Structure Therapeutics

0.02

Correlation Coefficient

Arcellx  Structure Therapeutics

Significant diversification

The 3 months correlation between Arcellx and Structure is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Arcellx and Structure Therapeutics

Given the investment horizon of 90 days Arcellx is expected to generate 0.66 times more return on investment than Structure Therapeutics. However, Arcellx is 1.52 times less risky than Structure Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.08 per unit of risk. If you would invest  7,835  in Arcellx on December 29, 2024 and sell it today you would lose (1,039) from holding Arcellx or give up 13.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arcellx  vs.  Structure Therapeutics America

Arcellx

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Structure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Arcellx and Structure Therapeutics

The main advantage of trading using opposite Arcellx and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.

The idea behind Arcellx and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.